We are live on ! Find out more
PA

Pinnacle Associates Portfolio holdings

AUM $7.78B
1-Year Est. Return 45.07%
This Fund
S&P 500
This Quarter Est. Return
-3.32%
1 Year Est. Return
+45.07%
3 Year Est. Return
+102.47%
5 Year Est. Return
+115.95%
10 Year Est. Return
+586.2%
AUM
$4.36B
AUM Growth
-$229M
Cap. Flow
+$4.73M
Cap. Flow %
0.11%
Top 10 Hldgs %
20.05%
Holding
776
New
30
Increased
264
Reduced
372
Closed
36

Sector Composition

Rank Sector Weight
1 Technology 21.97%
2 Healthcare 14.78%
3 Industrials 10.12%
4 Financials 8.35%
5 Communication Services 8.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NXPI icon
151
NXP Semiconductors
NXPI
$56.4B
$7.56M 0.17%
51,251
+733
+1% +$123K
VO icon
152
Vanguard Morningstar Mid-Cap ETF
VO
$107B
$7.55M 0.17%
160,576
+4,504
+3% +$235K
WBD icon
153
Warner Bros
WBD
$65.8B
$7.53M 0.17%
655,072
-18,520
-3% -$252K
LOW icon
154
Lowe's Companies
LOW
$117B
$7.46M 0.17%
39,735
+1,228
+3% +$239K
GD icon
155
General Dynamics
GD
$104B
$7.31M 0.17%
34,446
+212
+0.6% +$47.9K
XYL icon
156
Xylem
XYL
$27.7B
$7.29M 0.17%
83,420
-1,566
-2% -$142K
IEMG icon
157
iShares Core MSCI Emerging Markets ETF
IEMG
$152B
$7.28M 0.17%
169,298
-33,613
-17% -$1.61M
MTCH icon
158
Match Group
MTCH
$9.37B
$7.19M 0.17%
150,624
-4,201
-3% -$264K
STZ icon
159
Constellation Brands
STZ
$22.4B
$7.12M 0.16%
30,982
-1,595
-5% -$389K
COP icon
160
ConocoPhillips
COP
$145B
$7M 0.16%
68,445
-695
-1% -$69.3K
SAGE
161
DELISTED
Sage Therapeutics
SAGE
$6.61M 0.15%
168,766
-5,632
-3% -$218K
TVRD
162
Tvardi Therapeutics
TVRD
$18.9M
$6.6M 0.15%
19,594
-1,037
-5% -$376K
UNP icon
163
Union Pacific
UNP
$172B
$6.53M 0.15%
33,520
+174
+0.5% +$38.5K
PARA
164
DELISTED
Paramount Global Class B
PARA
$6.52M 0.15%
342,407
+27,760
+9% +$666K
GIS icon
165
General Mills
GIS
$19.1B
$6.5M 0.15%
84,891
+559
+0.7% +$42.6K
DY icon
166
Dycom Industries
DY
$12.6B
$6.49M 0.15%
67,915
-1,375
-2% -$144K
IMGN
167
DELISTED
Immunogen Inc
IMGN
$6.45M 0.15%
1,348,963
-41,569
-3% -$219K
DVN icon
168
Devon Energy
DVN
$51.2B
$6.29M 0.14%
104,629
+3,831
+4% +$238K
SHEL icon
169
Shell
SHEL
$252B
$6.14M 0.14%
123,373
-2,325
-2% -$120K
CL icon
170
Colgate-Palmolive
CL
$72.4B
$6.03M 0.14%
85,864
-2,315
-3% -$182K
FDN icon
171
First Trust Dow Jones Internet Index Fund ETF
FDN
$5.33B
$5.89M 0.14%
46,697
+80
+0.2% +$11.1K
PLD icon
172
Prologis
PLD
$134B
$5.86M 0.13%
57,653
+6,166
+12% +$765K
MMM icon
173
3M
MMM
$91.1B
$5.86M 0.13%
63,387
-6,852
-10% -$752K
FANG icon
174
Diamondback Energy
FANG
$55.8B
$5.82M 0.13%
48,320
-1,255
-3% -$157K
SCZ icon
175
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.3B
$5.76M 0.13%
118,183
-20,529
-15% -$1.13M

Similar funds

Pinnacle Associates's Q3 2022 Portfolio in Review

As of Q3 2022, Pinnacle Associates held 776 positions worth $4.36B, down 5% from $4.59B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Pinnacle Associates's Q3 2022 filing shows 30 new, 264 increased, 372 reduced and 36 closed positions. Its largest new stake was GSK: 40,198 shares worth $1.18M. The largest sale was Vanguard Short-Term Corporate Bond ETF, an estimated $20.7M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Industrials.

  • Pinnacle Associates's largest Q3 2022 buy was GSK: 40,198 shares worth $1.18M.
  • Pinnacle Associates added most to Johnson & Johnson in Q3 2022, an estimated $67.8M increase.
  • Pinnacle Associates's biggest Q3 2022 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $20.7M.
  • Pinnacle Associates fully exited Mandiant, Inc. Common Stock in Q3 2022, selling an estimated $13.9M.
  • Pinnacle Associates's ten largest holdings make up 20% of its $4.36B portfolio in Q3 2022.
  • Pinnacle Associates opened 30 new positions and closed 36 in Q3 2022.
  • Pinnacle Associates's portfolio value fell 5% quarter-over-quarter to $4.36B.

Based on Pinnacle Associates's 13F filing for Q3 2022, filed 1 Nov 2022.